Living, Breathing Logistics

The supply of cell and gene therapies is a delicate operation – and easily broken, just like daisy chains.

01/31/2019

Download our supplement for discussion, debate and solutions.

With CAR-Ts approved in both the US and the EU, the advanced therapies field is answering the scientific questions of efficacy and safety – cell and gene therapies are becoming therapeutic realities. But new challenges are emerging...

How can manufacturing become more closed and automated to reduce the risks associated with human intervention and manual operations? How does the field overcome the problem of handling living breathing cells in transit? And are healthcare systems ready for cell and gene therapies?

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.